Outcome/Proceeding of Annual General Meeting of the Company

Reg Office: G2 & G3 Samarpan Complex, Next to Mirador Hotel, Chakala, Andheri East, Mumbai – 400099 Email Id: bacilpha@yahoo.com, CIN: L24200MH1987PLC043427, Tel: 22618452/22661541, Tel/Fax: 22618327 Date: September 23, 2026 Corporate Relationship Department BSE Limited, Phiroze Jeejeebhoy Towers, Dalal Street, Fort, Mumbai – 400001. Scrip Code: 524516 Sub: Proceedings of the 39th Annual General Meeting (AGM) of the Company held on September 23, 2026. Dear Sir(s), In terms of Regulation 30 and Part - A of Schedule III of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are enclosing herewith the summary of proceedings of the 38th Annual General Meeting of the Company held on Wednesday, September 23rd 2026 at 03:00 p.m. (IST) through two- way Video Conferencing (“VC”)/ Other Audio-Visual Means (“OAVM”). Kindly take the above intimation on your record. Yours faithfully, For BACIL PHARMA LIMITED CHAITALI KALPATARU SHAH DIRECTOR DIN: 11167778 Encl: as above. SUMMARY OF PROCEEDINGS OF 39TH ANNUAL GENERAL MEETING OF BACIL PHARMA LIMITED HELD ON WEDNESDAY, SEPTEMBER 23, 2026 AT 3.00 P.M. IST THROUGH TWO-WAY VIDEO CONFERENCING (“VC”) / OTHER AUDIO-VISUAL MEANS (“OAVM”) A. DATE, TIME AND VENUE OF THE MEETING: In terms of the General Circular No.14/2020 dated April 08, 2020, 17/2020 dated April 13, 2020, 20/2020 dated May 05, 2020, 10/2022 dated December 28, 2022 (‘‘MCA Circulars’’) and Circular No. SEBI/HO/CFD/CMD1/ CIR/P/2020/79 dated May 12, 2020, SEBI/HO/CFD/CMD2/ CIR/P/2021/11 dated January 15, 2021, SEBI/HO/CFD/CMD2/ CIR/P/2022/62 dated May 13, 2022 and Circular No. SEBI/ HO/ CFD/PoD- 2/P/CIR/2023/4 dated January 5, 2023 (“SEBI Circulars”) companies are allowed to hold AGM through video conference/other audio visual means (“VC/OAVM”) upto September 30, 2024 without the physical presence of members. In compliance with the applicable provisions of the Act, MCA & SEBI circulars, 39th Annual General Meeting (AGM) of the Members of Bacil Pharma Limited was held on Wednesday, September 23, 2026 at 3.00p.m. (IST) through two- way Video Conferencing (“VC”) / Other Audio Visual Means (“OAVM”) Total 66 members attended the meeting as per the records of attendance. B. PROCEEDINGS IN BRIEF: After ascertaining that the requisite number of members were present through two- way VC/OAVM, Ms. Chaitali Kalpataru Shah, Director of the Company presided over the Meeting and welcomed all the members. The Meeting was held through VC/ OAVM in compliance with the circulars issued by the Ministry of Corporate Affairs, Government of India and Securities and Exchange Board of India. He further informed that the Company had tied up with NSDL to provide facility for voting through remote e-voting and National Securities Depository Limited (NSDL) have been appointed for providing facilities of e-voting during the AGM and conducting the AGM through VC/ OAVM facility. The Chairman informed to the members that: In accordance with the provisions of the Companies Act, 2013 and SEBI Listing Regulations, the Members have been provided the facility to exercise their right to vote by electronic means, either through remote e-voting or by e- voting at the AGM. Members joining the meeting through video conferencing, who have not cast their vote by remote e-voting, may vote through e-voting facility provided by National Securities Depository Limited (NSDL) at the AGM. The Members who have cast their vote by remote e-voting prior to the AGM shall not be entitledt o cast their vote again. Thereafter, Ms. Chaitali Kalpataru Shah delivered the Chairman’s speech at the Annual General Meeting. Further, with the permission of the members, the Chairman declared that the Notice convening the AGM and the Directors’ Report, were taken as read. Thereafter the Chairman read out the following items of business as per the Notice of 39th Annual General Meeting dated September 23, 2026 which were to be carried by the members at the meeting: Sl. Particulars Type of No. Resolution ORDINARY BUSINESS: 1. Adoption of the Audited Financial Statements of the Ordinary Company for the Financial Year ended March 31, 2026, Resolution including the Audited Balance Sheet as at March 31, 2026, the Statement of Profit and Loss & Cash Flow Statement for the Year ended on that date together with the Reports of the Board of Directors and Auditors thereon. 2. To appoint a Director in place of Ms. Chaitali Ordinary Kalpataru Shah (DIN: 11167778), who retires by Resolution rotation at this Annual General Meeting and being eligible, offers herself for re-appointment. SPECIAL BUSINESS: 3. Change in Designation of Ms. Chaitali Kalpataru Shah Special (DIN: 11167778) from Executive Director to Resolution Managing Director of the Company. 4. Re-appointment of Mr. Omprakash Pyarelal Sonar Special (DIN: 11031877) as Non - Executive Independent Resolution Director of the Company. 5. Re-appointment of Mr. Vivek Mukesh Yadav (DIN: Special 11033957) as Non - Executive Independent Director Resolution of the Company. 6. To appoint M/s Sarang Shivajirao Chavan & Special Associates Chartered Accountants (FRN: 159649W) Resolution as Statutory Auditors of the Company and fix their remuneration. 7. Increase in Authorised Share Capital of the Company Ordinary and alteration of capital clause of memorandum of Resolution association of the company. 8. Re-appointment of Mr. Mahesh Singh (DIN: Special Resolution 11814569) as Non - Executive Independent Director of the Company. 9. Re-appointment of Mr. Anil Singh (DIN: 09338444) as Special Resolution Non - Executive Non-Independent Director of the Company. The Chairman also informed the members about the following: i. The remote e-voting period had commenced on Sunday, September 20th, 2026 (9:00 am) (IST) and ends on Tuesday, September 22nd, 2026 (5:00 pm) (IST). ii. The Company had provided a facility to the members to cast their votes electronically. Members who had not cast their votes through remote e- voting platform were provided with an opportunity to cast their votes, electronically during the AGM and a time period of 15 minutes would be available for voting at the meeting after which the meeting will stand closed. iii. The Company has appointed Mr. Ramesh Chandra Bagdi, Practicing Company Secretary of M/s. Ramesh Chandra Bagdi & Associates, Company Secretaries, as Scrutinizer to conduct the process in a fair and transparent manner. Thereafter, the Chairman announced that all the business set out in the Notice of the meeting had been concluded. The voting results along with the Scrutinizer’s Report will be made available on the Company's website at www.markobenzventures.com and will be simultaneously be communicated to the Stock Exchange within 48 hours from the conclusion of the AGM. The Chairman on behalf of the Board thanked the Shareholders for attending and participating at the AGM. The 39th Annual General Meeting of the Company concluded at 03.11 p.m. (IST). Yours faithfully, For Bacil Pharma Limited Chaitali Kalpataru Shah Director DIN: 11167778